Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01738451 |
| Title | A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | GBR | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Scottsdale | Arizona | 85259 | United States | Details | |
| GSK Investigational Site | Memphis | Tennessee | 38120 | United States | Details | |
| GSK Investigational Site | Nashville | Tennessee | 37203 | United States | Details | |
| GSK Investigational Site | San Antonio | Texas | 78229 | United States | Details | |
| GSK Investigational Site | Salt Lake City | Utah | 84112-5550 | United States | Details | |
| GSK Investigational Site | Heidelberg | Victoria | 3084 | Australia | Details | |
| GSK Investigational Site | Melbourne | Victoria | 3004 | Australia | Details | |
| GSK Investigational Site | London | W1G 6AD | United Kingdom | Details |